ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-Noon @EverythingALS
ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-Noon @EverythingALS
Uploaded September 2023 | Updated September 2026, 2 weeks ago
Mr.Alon Ben-Noon is the Co-Founder and CEO of NeuroSense Therapeutics.

Mr Alon Ben-Noon is a Life Science Executive who prior to the establishment of NeuroSense, founded MediCan Consulting, a successful consultancy firm with clients from diversified biotech companies, and mainly in the neurodegenerative space. MediCan excelled at executing efficient, accurate, and innovative drug development programs for its clients. Prior to that, Alon worked at Teva and Perrigo.


Join ALS research
everythingals.org/research
ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-NoonAssistive Technology for Communication: From Selection to CustomizationsRecent Genomic and Proteomic Advances in ALS/FTD with Dr. Bryan TraynorHi from Pathfinders Shawn and JoePalliative Care for ALS: What is it? How can it help? How to access it?To Kill a Motor Neuron: Model systems in the lab to understand ALS in the clinicALS Citizen led ResearchRespiratory Conditions in ALSStories and Innovation in ALS Episode #19: Detoxification & Biochemical Resilience with Dr. ShadeNutritional Considerations in ALS: Is there a role for nutritional guidance in the treatment of ALS?Three Molecular Subtypes of ALS: #ExpertTalk with Dr. Molly Gale HammellIs ALS a recoverable disease? Insights from Dr. Brett Morrison
Everything ALS |

ALS Therapies and Treatment Updates: Updates on PrimeC by Mr.Alon Ben-Noon

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER